A detailed history of Eagle Bay Advisors LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 582 shares of KOD stock, worth $4,690. This represents 0.0% of its overall portfolio holdings.

Number of Shares
582
Previous 582 -0.0%
Holding current value
$4,690
Previous $1,000 400.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$3.01 - $7.45 $902 - $2,235
300 Added 106.38%
582 $3,000
Q2 2022

Aug 19, 2022

BUY
$5.04 - $9.48 $1,421 - $2,673
282 New
282 $2.15 Million
Q1 2022

May 11, 2022

SELL
$7.09 - $89.45 $226 - $2,862
-32 Closed
0 $0
Q4 2021

Jan 21, 2022

BUY
$80.85 - $128.49 $2,587 - $4,111
32 New
32 $3,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $419M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Eagle Bay Advisors LLC Portfolio

Follow Eagle Bay Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.